Dexmedetomidine
- Strength
- 100 ug/mL
- Form
- Injection, Solution, Concentrate
- Class
- Central alpha-2 Adrenergic Agonist
WG Critical Care, LLC
Not stocked by us — reference only
Listed by Baxter Healthcare Corporation
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Central alpha-2 Adrenergic Agonist |
| Approval route | ANDA — approved generic |
| NDC code | 36000-262 |
| FDA application | ANDA208103 |
| RxNorm concept | 309710 |
| Package sizes listed | 3 |
| Marketed since | April 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
WG Critical Care, LLC
Not stocked by us — reference only
WG Critical Care, LLC
Not stocked by us — reference only
Accord Healthcare Inc.
Not stocked by us — reference only
Piramal Critical Care Inc
Not stocked by us — reference only
Avenacy Inc.
Not stocked by us — reference only
ProPharma Distribution
Not stocked by us — reference only
Medical Purchasing Solutions, LLC
Not stocked by us — reference only
Piramal Critical Care Inc
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.